Cargando…
维奈克拉联合阿扎胞苷治疗急性髓系白血病的近期疗效：单中心数据
OBJECTIVE: To explore the safety and short-term efficacy of venetoclax combined with azacitidine (Ven+AZA) in previously untreated patients unfit for standard chemotherapy and patients with relapsed/refractory (R/R) acute myeloid leukemia (AML) in China. METHODS: A retrospective study was conducted...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980640/ https://www.ncbi.nlm.nih.gov/pubmed/35381674 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2022.02.008 |